The Bigger Picture Ozempic, Wegovy, Mounjaro, and Zepbound are not replacing your DMARDs or your biologics
It requires careful management to prevent complications and maintain a good quality of life
Familiar Failures: The 1990s and 2000s After Fen-Phen, the industry tried new approaches, with mixed results
The TrumpRx deal suggests both Lilly and Novo will face continued pressure to expand access and reduce costs
Providers consider appetite patterns, existing medical conditions, lifestyle habits, side effect tolerance, and long-term health goals before recommending treatment
Additionally, exenatide increased cerebral glucose metabolism in regions associated with glucose homeostasis, appetite, and food reward, as observed through [(18)F]2-fluoro-2-deoxy-d-glucose PET/CT scans [17,18,19]